Cardiff Oncology Reports First Quarter 2022 Results and Prov

Reported new Phase 1b/2 data from lead KRAS-mutated metastatic colorectal cancer (mCRC) clinical program showing objective response rate and median...

Related Keywords

United States , American , Heinz Josef Lenz , Acta Oncologica , Mark Erlander , Amy Jobe , Joyce Allaire , James Levine , Cardiff Oncology Inc , Crc Program , Prnewswire Cardiff Oncology Inc , Nasdaq , Exchange Commission , Crpc Program , American Association For Cancer Research , Lifesci Communications , Norris Comprehensive Cancer Center , Cardiff Oncology , Comprehensive Cancer Center , American Society , Castration Resistant Prostate Cancer , American Association , Cancer Research , Annual Meeting , Months Ended March , Lancet Oncol , Correspondence Lancet Oncol June , Private Securities Litigation Reform Act , Oncology Contact , Nc ,